Come up with a name for your new list and we'll add to it:
Variation Biotechnologies was acquired by
Paulson Investment Company on May 09, 2014.
Variation Biotechnologies is a vaccine company which leverages bioinformatics to develop synthetic vaccines against highly variant pathogens. VBI's approach to vaccine development and growing pipeline…